Creative Medical Technology Holding... (CELZ)
$4.92
-0.30 (-5.75%)
Rating:
Recommendation:
-
| Symbol | CELZ |
|---|---|
| Price | $4.92 |
| Beta | 5.244 |
| Volume Avg. | 0.05M |
| Market Cap | 7.038M |
| Shares () | - |
| 52 Week Range | 3.3-14.2 |
| 1y Target Est | - |
| DCF Unlevered | CELZ DCF -> | |
|---|---|---|
| DCF Levered | CELZ LDCF -> | |
| ROE | -55.29% | Strong Sell |
| ROA | -65.05% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | - | |
| P/E | -0.67 | |
| P/B | 0.51 | Buy |
Latest CELZ news
About
Download (Excel)Mr. Timothy Warbington
Healthcare
Biotechnology
NASDAQ Capital Market
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.